You are viewing a javascript disabled version of the site. Please enable Javascript for this site to function properly.
Go to headerGo to navigationGo to searchGo to contentsGo to footer
In content section. Select this link to jump to navigation

Polyethylenimine derivate conjugated with RGD-TAT-NLS as a novel gene vector

Issue title: Frontiers in Biomedical Engineering and Biotechnology – Proceedings of the 3rd International Conference on Biomedical Engineering and Biotechnology, 25–28 September 2014, Beijing, China

Article type: Research Article

Authors: Zhao, Wenfang | Liu, Kehai; | Chen, Shunsheng | Zhu, Man man | Lv, Hui | Hu, Jing | Mao, Yuan

Affiliations: Department of Biopharmaceutics, College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China

Note: [] Corresponding author: Kehai Liu, Department of Biopharmaceutics, College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China. Tel.: +086-21-61900388; Fax: +086-21-61900365; E-mail: [email protected].

Keywords: Non-viral gene vector, polyethylenimine, P123, nuclear localization signal, avß3

DOI: 10.3233/BME-141002

Journal: Bio-Medical Materials and Engineering, vol. 24, no. 6, pp. 1933-1939, 2014

Published: 2014
Get PDF open access

Abstract

To solve the contradiction between the cell toxicity and transfection efficiency of polyethylenimine (PEI) derivate in non-viral gene therapy, a novel gene vector, P123-PEI-R18 was synthesized by using biodegradable PEI derivate conjugated with trifunctional peptide RGD-TAT-NLS. The particle size of P123-PEI-R18/DNA was around 100–250nm. The gene vector could condense DNA at the weight ratio of 2 and protect plasmid DNA from being dissolved in the blood circulation. Importantly, the complexes exhibited lower cell toxicity and higher transfection efficiency contrasted with PEI 25 kDa in vitro. P123-PEI-R18 holds high potential as a safe and efficient gene vector.

Show more